anti-TIGIT

2 stories · following the connections

Business

OncoMed Announces Third Quarter 2017 Financial Results and Operational Highlights

By Nasdaq OMXNov 2, 2017, 8:06 PM UTC

Business

OncoMed Presents Preclinical Data for Anti-TIGIT Program at the American Association for Cancer Research Annual Meeting 2017

By Nasdaq OMXApr 3, 2017, 5:00 PM UTC